UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Corton Capital Inc.

Corton Capital Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 27.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,141 shares of the healthcare conglomerate’s stock after selling 435 shares during the period. Corton Capital Inc.’s holdings in UnitedHealth Group were worth $575,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Keebeck Wealth Management LLC grew its holdings in UnitedHealth Group by 11.6% during the second quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after acquiring an additional 1,122 shares during the period. D.A. Davidson & CO. boosted its position in shares of UnitedHealth Group by 24.0% in the 2nd quarter. D.A. Davidson & CO. now owns 42,045 shares of the healthcare conglomerate’s stock valued at $20,209,000 after purchasing an additional 8,144 shares during the period. Ascension Capital Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $216,000. Physician Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $207,000. Finally, Bartlett & Co. LLC boosted its position in shares of UnitedHealth Group by 5.7% in the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after purchasing an additional 8,873 shares during the period. 85.69% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH traded down $14.95 on Wednesday, reaching $498.47. 9,557,571 shares of the stock traded hands, compared to its average volume of 4,016,427. The firm has a market cap of $461.04 billion, a price-to-earnings ratio of 21.18, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The stock’s 50-day moving average price is $520.36 and its 200-day moving average price is $519.17.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the prior year, the business posted $5.34 earnings per share. The business’s revenue was up 14.1% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.84 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th will be issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s payout ratio is presently 31.54%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the transaction, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages have commented on UNH. HSBC restated a “reduce” rating and set a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Jefferies Financial Group decreased their price objective on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a research report on Monday, November 20th. Piper Sandler decreased their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Truist Financial reiterated a “buy” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Thursday, November 30th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a report on Tuesday, January 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $575.79.

Read Our Latest Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.